Diagnosis: Novel molecular signatures for adrenocortical carcinoma

Nature Reviews Endocrinology

Volumn 5, Issue 6, 2009, Pages 297-299

  Betz, Matthias J ^a   Beuschlein, Felix ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MOLECULAR MARKER; BUB1 SPINDLE CHECKPOINT PROTEIN; DLG7 PROTEIN, HUMAN; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PTEN INDUCED PUTATIVE KINASE; PTEN-INDUCED PUTATIVE KINASE; TUMOR PROTEIN;

ADRENAL CORTEX CARCINOMA; BUB1B GENE; CANCER INVASION; DIFFERENTIAL DIAGNOSIS; DLG7 GENE; EARLY DIAGNOSIS; GENE; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SCREENING; HUMAN; PINK1 GENE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SCORING SYSTEM; SHORT SURVEY; METABOLISM; NOTE; PATHOLOGY; PHYSIOLOGY;

ADRENOCORTICAL CARCINOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 68949092309     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.93     Document Type: Short Survey

References (8)

1. De Reyniès, A. et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J. Clin. Oncol. 27, 1108-1115 (2009).
2. Allolio, B. & Fassnacht, M. Clinical review: adrenocortical carcinoma: clinical update. J. Clin. Endocrinol. Metab. 91, 2027-2037 (2006).
3. DeLellis, R. A., Lloyd, R. V., Heitz, P. U. & Eng, C. (eds) Pathology and Genetics of Tumours of Endocrine Organs (IARC WHO Classification of Tumours) (iARC Press, Lyon, 2004).
4. Fassnacht, M. et al. Limited prognostic value of the 2004 international Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TnM classification. Cancer 115, 243-250 (2009).
5. Volante, M., Buttigliero, C., Greco, E., Berruti, A. & Papotti, M. Pathological and molecular features of adrenocortical carcinoma: an update. J. Clin. Pathol. 61, 787-793 (2008).
6. Giordano, T. J. et al. Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 15, 668-676 (2009).
7. First international Randomized trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FiRM-ACT), firm act study [online] www.firm-act.org (2009).
8. Ronchi, C. et al. expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. Endocr. Relat. Cancer doi:10.1677/eRC-08-0224 (2009).